Public Profile

Otsuka Pharmaceutical

Otsuka Pharmaceutical Co., Ltd., commonly referred to as Otsuka, is a leading global healthcare company headquartered in Japan. Established in 1964, Otsuka has made significant strides in the pharmaceutical and nutraceutical industries, focusing on innovative solutions for mental health, oncology, and general healthcare. With a strong presence in regions such as North America, Europe, and Asia, Otsuka is renowned for its unique products, including the antipsychotic medication Abilify and the hydration solution Pocari Sweat. The company’s commitment to research and development has positioned it as a pioneer in addressing unmet medical needs. Otsuka's dedication to innovation and patient care has earned it a notable reputation in the global market, making it a key player in the pharmaceutical landscape.

DitchCarbon Score

How does Otsuka Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

60

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Otsuka Pharmaceutical's score of 60 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.

96%

Let us know if this data was useful to you

Otsuka Pharmaceutical's reported carbon emissions

In 2023, Otsuka Pharmaceutical reported total carbon emissions of approximately 776,000,000 kg CO2e globally, with Scope 1 emissions at about 109,739,000 kg CO2e and Scope 2 emissions at approximately 1,395,000 kg CO2e. The company has set ambitious climate commitments, aiming for a 50% reduction in Scope 1 and Scope 2 emissions by 2028, compared to 2017 levels. This target was accelerated from a previous goal set for 2030. Otsuka's emissions profile also includes significant Scope 3 emissions, which total around 664,646,000 kg CO2e, highlighting the importance of addressing indirect emissions in their sustainability strategy. The company is actively working towards its long-term vision of achieving net-zero emissions by 2050, which encompasses all scopes of emissions. These commitments reflect Otsuka's dedication to reducing its environmental impact and aligning with global climate action initiatives.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2011201220172020202120222023
Scope 1
285,728,000
000,000,000
-
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
116,816,000
000,000,000
-
00,000,000
0,000,000
0,000,000
0,000,000
Scope 3
402,544,000
000,000,000
-
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Otsuka Pharmaceutical's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Otsuka Pharmaceutical is in JP, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Otsuka Pharmaceutical is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Takeda

JP
Pharmaceutical Preparation Manufacturing
Updated about 10 hours ago

Sandoz International GmbH

DE
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Luye Pharma

CN
Pharmaceutical Preparation Manufacturing
Updated 24 days ago

Allergan, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Lundbeck

DK
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Ajinomoto

JP
Food products nec
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers